Site Group Page (References Reporting High Throughput Detection Method)
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Site Group Page (References Reporting High Throughput Detection Method)
 

Site Information
RhoGDI alpha (human) K141-a RKGVKIDkTDYMVGS 1, 2, 4, 5
RhoGDI alpha iso3 (human) K141-a RKGVKIDkTDYMVGS
RhoGDI alpha (mouse) K141-a RKGVKIDkTDYMVGS 3
RhoGDI alpha (rat) K141-a RKGVKIDkTDYMVGS

References

1

(2010) CST Curation Set: 9920; Year: 2010; SILAC: N; Biosample/Treatment: K-562(cell line)/untreated; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK
Curated Info

2

Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-40
19608861   Curated Info

3

(2008) CST Curation Set: 5043; Year: 2008; SILAC: N; Biosample/Treatment: Dana Farber-L1(tissue)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK Antibody Used to Purify Peptides prior to MS2: Acetylated-Lysine (Ac-K2-100) Rabbit mAb Cat#: 9814, PTMScan(R) Acetyl-Lys Motif (Ac-K) Immunoaffinity Beads Cat#: 1989
Curated Info

4

Kim SC, et al. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23, 607-18
16916647   Curated Info

5

(2005) CST Curation Set: 967; Year: 2005; SILAC: N; Biosample/Treatment: HCT116(cell line)/EGF; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-AcK Antibody Used to Purify Peptides prior to MS2: Acetylated-Lysine Antibody Cat#: 9441
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.